23 citations
,
January 1986 Involucrin is crucial for skin cell maturation and protection.
September 2023 in “Journal of the American Academy of Dermatology” Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.
2 citations
,
May 2018 in “Dermatologic Surgery” 1 citations
,
January 2024 in “Egyptian Dental Journal /Egyptian Dental Journal” The combined treatment improves lip texture, elasticity, and firmness for up to nine months.
May 2016 in “American Academy of Pediatrics eBooks” Telogen effluvium is a condition that causes temporary hair loss.
January 2017 in “Elsevier eBooks” Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.
39 citations
,
January 1977 in “Dermatology” The treatment cleared psoriasis in some patients but caused side effects in most.
2 citations
,
April 2018 in “Journal of Investigative Dermatology” The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.
January 2023 in “Burns & Trauma” The study concluded that the new wound model can be used to evaluate skin regeneration and nerve growth.
January 2026 in “Dermatology Practical & Conceptual” Exosomes can improve skin elasticity, reduce wrinkles, and enhance hydration, but more research is needed.
10 citations
,
November 1993 in “Indian Journal of Dermatology Venereology and Leprology” Minoxidil can cause erythema multiforme, even if patch tests are negative.
1 citations
,
August 2023 in “International Journal of Molecular Sciences” Platelet Rich Plasma-Derived Extracellular Vesicles show promise for healing and regeneration but need standardized methods for consistent results.
December 2024 in “Medical alphabet” Understanding and addressing the causes of telogen effluvium is crucial for effective treatment.
28 citations
,
April 1936 in “Journal of the American Medical Association” Aloe vera healed severe skin damage and restored normal skin in five weeks.
70 citations
,
January 2015 in “Journal of Clinical and Diagnostic Research” Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.
February 2015 in “Rivm (National Institute for Public Health and the Environment)” Cosmetics in the Netherlands were mostly safe but sometimes caused allergic reactions, leading to potential bans on certain ingredients.
4 citations
,
September 2024 in “PubMed” There's not enough evidence to prove platelet-rich plasma works for facial rejuvenation.
December 2020 in “Jurnal Wiyata: Penelitian Sains dan Kesehatan” Aloe vera peel extract gel helps speed up the healing of minor burns in rabbits.
5 citations
,
August 1925 in “Archives of dermatology” An 8-year-old boy with Recklinghausen's Disease shows various symptoms and is from a family with close genetic ties.
51 citations
,
November 2018 in “JAMA Dermatology” PRP injections may improve skin texture and wrinkles based on patient feedback, despite no significant changes seen by dermatologists.
April 2026 in “Biomaterials” The FDA did not approve a testosterone drug because of safety concerns.
Elastin-like recombinamers show promise for better wound healing and skin regeneration.
February 2021 in “Pakistan Armed Forces Medical Journal” A rare skin condition usually found near the eyes was found on a farmer's scalp.
January 2018 in “Jaypee Brothers Medical Publishers (P) Ltd. eBooks” Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.
January 2014 in “Jaypee Brothers Medical Publishers (P) Ltd. eBooks” Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.
January 1998 in “Jaypee Brothers Medical Publishers (P) Ltd. eBooks” Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.
3 citations
,
February 2023 in “International Journal of Molecular Sciences” Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.
25 citations
,
July 1994 in “Archives of Dermatology” A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.
4 citations
,
October 2019 in “Acta Médica Costarricense” More research is needed to standardize and prove the effectiveness of platelet-rich plasma treatments.